← Back to Search

Desperation Scale Evaluation for Suicide Risk

N/A
Waitlist Available
Research Sponsored by National Center for Research Resources (NCRR)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights

Study Summary

This trial is testing a new desperation scale to see if it can better predict suicide than existing measures. The scale consists of three elements: a sense of entrapment, feelings of anxiety/agitation, and a sense of time urgency.

Who is the study for?
This trial is for young adolescents aged 10-16 who visit the pediatric emergency room at Yale-New Haven Hospital and need a psychiatric consultation. They must be able to give consent, read English, and not have psychotic or organic brain disorders, low IQ, or learning disabilities.Check my eligibility
What is being tested?
The study tests 'The Desperation Scale,' a new tool designed to measure desperation in suicidal youths by assessing feelings of entrapment, anxiety/agitation, and urgency. It aims to differentiate between suicidal and non-suicidal individuals more effectively than current methods.See study design
What are the potential side effects?
Since this trial involves completing a questionnaire rather than taking medication or undergoing medical procedures, there are no direct physical side effects associated with participating in this study.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Find a Location

Who is running the clinical trial?

National Center for Research Resources (NCRR)Lead Sponsor
537 Previous Clinical Trials
317,016 Total Patients Enrolled

Media Library

Treatment Clinical Trial Eligibility Overview. Trial Name: NCT00005566 — N/A
Suicide Attempt Research Study Groups:
Suicide Attempt Clinical Trial 2023: Treatment Highlights & Side Effects. Trial Name: NCT00005566 — N/A
Treatment 2023 Treatment Timeline for Medical Study. Trial Name: NCT00005566 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research encompass individuals of 18 years and older?

"Applicants between 10 and 16 years of age satisfy the inclusion criteria for this medical trial. In contrast, there are 58 studies recruiting participants below 18 and 120 that seek elderly adults over 65 years old."

Answered by AI
~233 spots leftby Apr 2025